CSI Singapore is proud to announce the promotion of Dr. Takaomi Sanda to Associate Professor.
Using AI, Research Team Discovers Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Recent Study by CSI Researchers Holds Promise for Improved Therapeutic Treatment of Tumours with Mutated p53.
NanoVar: Accurate Characterization of Patients' Genomic Structural Variants Using Low-depth Nanopore Sequencing.
Targeting Microtubules Sensitizes Drug Resistant Lung Cancer Cells to Lysosomal Pathway Inhibitors.
A Common MET Polymorphism Harnesses HER2 Signaling to Drive Aggressive Squamous Cell Carcinoma.
You can help us to shape the next generation of innovative cancer research
7th NCIS Annual Research Meeting
22 July - 25 July 2020
RNA Biology Symposium 2020
1 - 2 October 2020
Copyright © 2020 Cancer Science Institute of Singapore (CSI). All Rights Reserved.